Thus, the major phenotype of intestinal Slc16a1-deleted female mice was an aggravation of diet-induced obesity, associated with increases in blood cholesterol/LDL-C levels, a reduction in metabolic rate, and aggravated hepatic steatosis. Here, SLC16A1 is linked to obesity disorder.